Table 2.
Significant correlation of FMD and ccIMT at baseline (T0) and at 1 year follow-up (T1) with other parameters at T0 and T1, respectively
| FMD T0 | ccIMT T0 | FMD T1 | ccIMT T1 | ||
|---|---|---|---|---|---|
|
| |||||
| 5.52 (0.04), 5.42–5.61 | 0.77 (0.01), 0.74–0.80 | 5.604 (0.04), 5.50–5.70 | 0.74 (0.001), 0.71–0.77 | ||
| CRP (mg/dL) T0 | 1.37 (0.1), 1.04–1.70 | Not significant | Not significant | – | – |
| CRP T1 | 0.83 (0.12), 0.57–1.1 | – | – | p=0.0075 | Not significant |
| TNFα T0 | 21.49 (3.6), 14.14–28.84 | Not significant | p=0.02 | – | – |
| TNFα T1 | 25.80 (6.09), 6.01–14.43 | – | – | Not significant | p=0.02 |
| CD3/CD8+T0 | 514.3 (42.6), 428.5–600.2 | Not significant | Not significant | – | – |
| CD3/CD8+T1 | 500.2 (35.53), 428.6–571.9 | – | – | Not significant | p=0.03 |
Note: Values are expressed in mean, SEM, and 95% CI.
Abbreviations: CRP (mg/dL), C-reactive protein; FMD, flow-mediated dilation; SEM, standard error mean; TNFα (pg/mL), tumor necrosis factor alpha; ccIMT, common carotid intima media thickness.